The URMC has a long and distinguished track record in HIV/AIDS research, dating back to the earliest days of the epidemic. UR was also a founding member of both the HIV Vaccine Trials Network (HVTN) and the AIDS Clinical Trials Group (ACTG), or their preceding organizations, and has a proud tradition of vaccine research – including the invention of ground-breaking technologies that were commercially licensed to develop the human papillomavirus (HPV) vaccines that are now used worldwide to protect against cervical and anogenital cancers.
The CFAR serves as an anchor for HIV/AIDS researchers at the URMC and a catalyst for innovation by providing leadership and infrastructure to create new interdisciplinary collaborations which result in high-impact research. View recent publications.
URMC Research Groups, Community Observe 25th Annual World AIDS Day »
November 27, 2013
URMC Named a Leader in LGBT Healthcare Equality »
July 16, 2013
UR Named Center for AIDS Research by the National Institutes of Health »
May 09, 2013
As Our Understanding of HIV Evolves, Grant Helps Providers Keep Pace »
February 19, 2013
URMC Observes World AIDS Day with Talks, Events, Concert »
November 19, 2012
The 5th annual HIV/AIDS Symposium in recognition of World AIDS Day will be held Tuesday December 3rd. The event will include a Scientific Poster Sessions and a keynote address from Dr. Steven Deeks from the University of California at San Francisco and Dr. Paul Johnson from The New England Primate Center, Harvard University.